Skip to main content
Premium Trial:

Request an Annual Quote

GeneLink's Sales Rise 17 Percent in Q3

NEW YORK (GenomeWeb News) – GeneLink today reported that its third-quarter revenues increased nearly 17 percent to $2.1 million from $1.8 million for the third quarter of 2008, with nearly all of its sales coming from its GeneWize nutritional and dermatological genetic testing services.

GeneLink posted a net loss of $784,000 for the quarter ended Sept. 30, an increase of 53 percent over its net loss of $514,000 for third quarter of 2008.

The Orlando, Fla.-based consumer genomics company said in a filing with the US Securities and Exchange Commission that it will require around $2 million in funding to pursue its marketing strategy. Without those funds, the firm said, it will likely continue to burn through cash and may not be able to continue operations.

GeneLink CEO Monte Taylor said in a statement that the firm has developed a new strategy for lowering the entry price of its LifeMap Me custom nutritional product in an effort to gain customers and increase revenues.

GeneLink finished the quarter with cash and cash equivalents of roughly $426,000.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.